Literature DB >> 22528152

Influenza virus titration, antigenic characterization, and serological methods for antibody detection.

Alexander Klimov1, Amanda Balish, Vic Veguilla, Hong Sun, Jarad Schiffer, Xiuhua Lu, Jacqueline M Katz, Kathy Hancock.   

Abstract

This chapter describes some commonly used methods of influenza virus titration, antigenic characterization, and serological methods by antibody detection. These methods are essential not only for virus characterization but also for identifying new antigenic variants, vaccine strain selection, and sero-epidemiologic studies of influenza virus transmission and prevalence. Virus titration methods such as the hemagglutination assay, 50% egg or tissue culture infectious dose, and plaque assay are employed to determine the amount of virus particles in a sample. The hemagglutination inhibition assay is a reliable, relatively simple and inexpensive technique to antigenically characterize isolates of influenza viruses. Serological methods such as virus neutralization and hemagglutination inhibition are the fundamental tools used in sero-epidemiologic studies of influenza virus transmission and prevalence and in the evaluation of vaccine immunogenicity. While serological methods rarely yield an early diagnosis of acute influenza virus infection, well-timed, paired acute, and convalescent serum samples may establish the diagnosis of a recent influenza infection even when attempts to detect the virus are negative.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528152     DOI: 10.1007/978-1-61779-621-0_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  51 in total

1.  A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model.

Authors:  Beth C Holbrook; Jong R Kim; Lance K Blevins; Matthew J Jorgensen; Nancy D Kock; Ralph B D'Agostino; S Tyler Aycock; Mallinath B Hadimani; S Bruce King; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2016-06-08       Impact factor: 5.422

2.  Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response.

Authors:  Lance K Blevins; John T Wren; Beth C Holbrook; Sarah L Hayward; W Edward Swords; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

3.  New functionally-enhanced soy proteins as food ingredients with anti-viral activity.

Authors:  Aizhan Sabirzhanovna Turmagambetova; Nadezhda Sergeevna Sokolova; Andrey Pavlinovich Bogoyavlenskiy; Vladimir Eleazarovich Berezin; Mary Ann Lila; Diana M Cheng; Vyacheslav Dushenkov
Journal:  Virusdisease       Date:  2015-08-15

4.  Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates.

Authors:  Jong R Kim; Beth C Holbrook; Sarah L Hayward; Lance K Blevins; Matthew J Jorgensen; Nancy D Kock; Kristina De Paris; Ralph B D'Agostino; S Tyler Aycock; Steven B Mizel; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

5.  Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States.

Authors:  Joanna A Pulit-Penaloza; Natosha Simpson; Hua Yang; Hannah M Creager; Joyce Jones; Paul Carney; Jessica A Belser; Genyan Yang; Jessie Chang; Hui Zeng; Sharmi Thor; Yunho Jang; Mary Lea Killian; Melinda Jenkins-Moore; Alicia Janas-Martindale; Edward Dubovi; David E Wentworth; James Stevens; Terrence M Tumpey; C Todd Davis; Taronna R Maines
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

6.  Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection.

Authors:  Beth C Holbrook; Sarah L Hayward; Lance K Blevins; Nancy Kock; Tyler Aycock; Griffith D Parks; Martha A Alexander-Miller
Journal:  Virology       Date:  2014-12-24       Impact factor: 3.616

7.  Evaluation of cytotoxicity and antiviral activity of Rhazya stricta Decne leaves extract against influenza A/PR/8/34 (H1N1).

Authors:  Abdulaziz Albeshri; Nabih A Baeshen; Thamer A Bouback; Abdullah A Aljaddawi
Journal:  Saudi J Biol Sci       Date:  2022-07-16       Impact factor: 4.052

8.  Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses.

Authors:  Benjamin S Chambers; Yang Li; Richard L Hodinka; Scott E Hensley
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

9.  Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model.

Authors:  Beth C Holbrook; Ralph B D'Agostino; Griffith D Parks; Martha A Alexander-Miller
Journal:  Vaccine       Date:  2016-08-08       Impact factor: 3.641

10.  Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCR.

Authors:  Belete Teferedegne; Andrew M Lewis; Keith Peden; Haruhiko Murata
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.